metricas
covid
Annals of Hepatology Safety and efficacy of treatment with pegylated interferon alpha-2a with ribavir...
Journal Information

Statistics

Follow this link to access the full text of the article

Safety and efficacy of treatment with pegylated interferon alpha-2a with ribavirin in chronic hepatitis C genotype 4
Juan José Urquijo*, Moisés Diago
,
Corresponding author
mdiagom@meditex.es

Corresponding author.
, Jaume Boadas, Ramón Planas, Ricard Solá§, Juan Angel del Olmo||, Javier Crespo, José Carlos Erdozaín**, María Dolores Antón††, Carlos Arocena‡‡, Dolores Suarez§§, Josep Giné||||, Josep M Barrera¶¶, Javier Gracia-Samaniego***, Ricardo Perez†††, Blai Dalmau‡‡‡, Miguel Montoro§§§
* Consorcio Hospital General Universitario de Valencia, Spain
Hospital de Terrassa, Barcelona, Spain
Hospital Germans Trias i Pujol, Badalona, Spain
§ Hospital del Mar, Barcelona, Spain
|| Hospital Clínico de Valencia, Spain
Hospital Valdecilla, Santander, Spain
** Hospital La Paz, Madrid, Spain
†† Hospital Dr. Peset, Valencia, Spain
‡‡ Fundación Jimenez Diaz, Madrid, Spain
§§ Hospital Arquitecto Marcide, Ferrol, Spain
|||| Hospital Verge de la Cinta, Tortosa, Spain
¶¶ Hospital Clinic, Barcelona, Spain
*** Hospital Carlos III, Madrid, Spain
††† Hospital General Universitario, Albacete, Spain
‡‡‡ Hospital Parc Tauli Sabadell, Spain
§§§ Hospital San Jorge Huesca, Spain
Ver más
Read
1946
Times
was read the article
413
Total PDF
1533
Total HTML
Share statistics
Article information
ISSN: 16652681
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 95 19 114
2025 11 121 18 139
2025 10 56 7 63
2025 9 51 9 60
2025 8 67 6 73
2025 7 105 6 111
2025 6 50 5 55
2025 5 41 4 45
2025 4 20 10 30
2025 3 25 2 27
2025 2 13 1 14
2025 1 18 1 19
2024 12 15 3 18
2024 11 29 11 40
2024 10 8 20 28
2024 9 13 5 18
2024 8 16 1 17
2024 7 18 2 20
2024 6 12 6 18
2024 5 27 3 30
2024 4 23 2 25
2024 3 25 4 29
2024 2 14 10 24
2024 1 10 7 17
2023 12 7 8 15
2023 11 15 6 21
2023 10 20 8 28
2023 9 8 0 8
2023 8 14 3 17
2023 7 10 5 15
2023 6 21 5 26
2023 5 33 2 35
2023 4 38 1 39
2023 3 28 6 34
2023 2 13 7 20
2023 1 9 8 17
2022 12 7 4 11
2022 11 10 4 14
2022 10 13 7 20
2022 9 8 3 11
2022 8 16 7 23
2022 7 17 11 28
2022 6 22 3 25
2022 5 20 5 25
2022 4 19 7 26
2022 3 20 10 30
2022 2 23 4 27
2022 1 26 5 31
2021 12 14 8 22
2021 11 8 8 16
2021 10 37 5 42
2021 9 35 5 40
2021 8 12 3 15
2021 7 11 7 18
2021 6 5 2 7
2021 5 10 2 12
2021 4 19 2 21
2021 3 11 3 14
2021 2 4 3 7
2021 1 3 2 5
2020 12 6 1 7
2020 11 5 6 11
2020 10 3 3 6
2020 9 5 1 6
2020 8 4 3 7
2020 7 5 1 6
2020 6 3 1 4
2020 5 9 7 16
2020 4 1 0 1
2020 3 6 3 9
2020 2 6 1 7
2020 1 5 4 9
2019 12 5 3 8
2019 11 2 3 5
2019 10 3 8 11
2019 9 2 6 8
2019 8 3 4 7
2019 7 1 9 10
2019 6 1 8 9
Show all

Follow this link to access the full text of the article

Article options
Tools